Integrated Biopharma Inc SEC filings INBP
Integrated Biopharma Inc has 557 filings in SEC EDGAR's recent list, going back to Nov 21, 1996. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 8, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 28, 2026 | Oct 28, 2026 |
| DEF 14A | Proxy statement | Oct 28, 2025 | Oct 28, 2025 |
| DEF 14A | Proxy statement | Oct 28, 2024 | Oct 28, 2024 |
| DEF 14A | Proxy statement | Oct 27, 2023 | Oct 27, 2023 |
| DEF 14A | Proxy statement | Oct 27, 2022 | Nov 28, 2022 |
| DEF 14A | Proxy statement | Oct 27, 2021 | Oct 27, 2021 |
| DEF 14A | Proxy statement | Oct 28, 2020 | Oct 28, 2020 |
| DEF 14A | Proxy statement | Oct 28, 2019 | Oct 28, 2019 |
| DEF 14A | Proxy statement | Oct 29, 2018 | Nov 26, 2018 |
| DEF 14A | Proxy statement | Oct 27, 2017 | Nov 27, 2017 |
| DEF 14A | Proxy statement | Oct 28, 2016 | Nov 28, 2016 |
| DEF 14A | Proxy statement | Oct 26, 2015 | Oct 26, 2015 |
| DEF 14A | Proxy statement | Oct 28, 2014 | Oct 28, 2014 |
| DEFA14A | Additional proxy material | Nov 6, 2013 | — |
| DEF 14A | Proxy statement | Oct 28, 2013 | Oct 28, 2013 |
| DEFA14A | Additional proxy material | Nov 5, 2012 | — |
| DEF 14A | Proxy statement | Oct 29, 2012 | Oct 28, 2012 |
| DEF 14A | Proxy statement | Oct 28, 2011 | Oct 28, 2011 |
| DEF 14A | Proxy statement | Oct 28, 2010 | Oct 28, 2010 |
| DEF 14A | Proxy statement | Oct 28, 2009 | Oct 28, 2009 |
| DEF 14A | Proxy statement | Oct 28, 2008 | Oct 28, 2008 |
| DEF 14C | Information statement | Aug 12, 2008 | Aug 12, 2008 |
| DEF 14C | Information statement | Apr 9, 2008 | Apr 9, 2008 |
| PRE 14C | Integrated biopharma, inc. | Apr 1, 2008 | Mar 31, 2008 |
| PRE 14C | Integrated biopharma, inc. | Mar 20, 2008 | Mar 20, 2008 |
| DEF 14C | Information statement | Mar 7, 2008 | Mar 6, 2008 |
| DEF 14A | Proxy statement | Oct 30, 2007 | Oct 29, 2007 |
| DEF 14A | Proxy statement | Nov 6, 2006 | Nov 6, 2006 |
| DEF 14A | Proxy statement | Oct 28, 2005 | Oct 28, 2005 |
| DEF 14A | Proxy statement | Oct 29, 2004 | Oct 29, 2004 |
| DEF 14C | Information statement | Aug 30, 2004 | Aug 30, 2004 |
| PRE 14C | Integrated biopharma, inc. | Aug 23, 2004 | Aug 23, 2004 |
| DEF 14A | Proxy statement | Oct 28, 2003 | Dec 31, 2003 |
| DEF 14A | Proxy statement | Jan 13, 2003 | Nov 27, 2002 |
| DEF 14A | Proxy statement | Nov 13, 2000 | Nov 22, 2000 |
| DEF 14A | Proxy statement | Nov 15, 1999 | Nov 24, 1999 |
| DEFA14A | Additional proxy material | Nov 7, 1997 | — |
| DEF 14A | Proxy statement | Oct 28, 1997 | Oct 28, 1997 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INBP (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hillside, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1016504
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.